Form 4: UNH Director Acquires Shares via Dividend Equivalents

Sentiment:

Insider Transaction Report


UnitedHealth Group Director Valerie C. Montgomery Rice M.D. acquired 43 shares of common stock through dividend equivalents on vested deferred stock units.

Summary

  • Valerie C. Montgomery Rice M.D., a Director of UnitedHealth Group Inc. (UNH), acquired 43 shares of common stock.
  • The acquisition occurred on December 16, 2025, at a price of $0 per share.
  • These shares represent dividend equivalents paid on vested deferred stock units.
  • Following this transaction, Ms. Montgomery Rice beneficially owns 6,940 shares of UNH common stock directly.

Sentiment

Score: 7

Explanation: The acquisition of shares, even through dividend equivalents, indicates continued alignment of a director's interests with shareholders and is a routine part of equity compensation.

Positives

  • The acquisition of shares, even through dividend equivalents, demonstrates continued equity ownership by a director, aligning interests with shareholders.

Future Outlook

N/A This report details a past transaction and does not contain forward-looking statements or guidance.

Industry Context

This is a routine insider transaction for a director, common across industries where executive and director compensation includes equity components and dividend reinvestment or equivalents on deferred stock units.

Stakeholder Impact

  • Shareholders: The transaction demonstrates continued equity ownership by a director, aligning interests with shareholders.

Key Dates

DateDescription
12/16/2025Date of transaction (acquisition of common stock)
12/18/2025Date of filing signature

Recommendation

hold

This Form 4 details a routine acquisition of shares by a director through dividend equivalents on vested deferred stock units. It does not provide new material information that would warrant a change in investment recommendation. The transaction is a standard part of director compensation and indicates continued alignment of interests, but it is not a significant open-market purchase or sale that would signal a change in company fundamentals or outlook.

Keywords

UnitedHealth Group, UNH, Form 4, Insider Transaction, Stock Acquisition, Director, Dividend Equivalents, Deferred Stock Units, Valerie C. Montgomery Rice

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.